EU Pharma Reform: Council Proposal A ‘Step In The Right Direction’ But ‘More Work To Be Done’

Experts from EUCOPE explain why the Council of the EU’s position on the proposed overhaul of the general pharmaceutical legislation could offer more predictability for companies than the commission’s initial offering.

The overhaul of the EU pharma legislation has passed another milestone (Shutterstock)

More from EU Pharma Legislation Reform

More from Patents